Publications

Peer-reviewed publications and selected preprints.

2025

  1. PBPK-PD model for predicting pharmacokinetics, tumor growth inhibition, and toxicity risks of topoisomerase inhibitor ADCs in mice and humans
    Zehua Wang, Jinwei Zhu, Lan Sang, Linxiu Tang, Sasa Zhang, Yongmei Tan, and 2 more authors
    European Journal of Pharmaceutical Sciences, 2025
  2. DMD
    Chronic liver injury decreases levels of cerebral carnitine and acetylcarnitine in rats partly due to the downregulation of organic cation transporters OCT1/2 and OCTN2 at the blood-brain barrier
    Hao Zhi, Zhongyan Wang, Xinyue Zhu, Wenhan Wu, Lu Yang, Yidong Dai, and 5 more authors
    Drug Metabolism and Disposition, 2025

2024

  1. Prediction of SPT-07A Pharmacokinetics in Rats, Dogs, and Humans Using a Physiologically-Based Pharmacokinetic Model and In Vitro Data
    Xiaoqiang Zhu, Weimin Kong, Zehua Wang, Xiaodong Liu, and Li Liu
    Pharmaceutics, 2024

2023

  1. Thioacetamide-Induced Acute Liver Injury Increases Metformin Plasma Exposure by Downregulating Renal OCT2 and MATE1 Expression and Function
    Hao Zhi, Yidong Dai, Lin Su, Lu Yang, Wenhan Wu, Zehua Wang, and 2 more authors
    Biomedicines, 2023
  2. Preprint
    Venlafaxine induces psychiatric disorders due to upregulation of cerebral catechol-O-methyltransferase via the PI3K/AKT/mTOR pathway
    Li Liu, Liqiang Qian, Hanyu Yang, Qianli Ye, Zijun Xu, Yanlin Liu, and 2 more authors
    2023